Conjunctival Hyperemia
Conjunctival Hyperemia - Related Videos
06:29
Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
0 Views •
2022
The present protocol describes the cross-sectional research performed on 40 healthy subjects between the ages of 20 and 45 to assess the prevalence of dry eye syndrome (DES) during COVID-19. The OSDI survey evaluated DES, and the advanced ophthalmic systems (AOS) software was used to assess limbal redness.
05:05
Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
0 Views •
2025
Here, we present a protocol for harvesting and processing conjunctival biopsy to identify mucous membrane pemphigoid.
04:45
Swab-based Conjunctival Commensal Bacteria Isolation: A Technique to Isolate Commensal Bacteria from Conjunctiva of Murine Model
0 Views •
2025
This video describes a swab-based technique to isolate viable commensal bacteria from the ocular conjunctiva. The technique can be used to profile the commensal bacterial microbiome of the conjunctiva, which plays a defensive role against pathogens.
07:52
Conjunctival Commensal Isolation and Identification in Mice
0 Views •
2021
Presented here is a protocol for the isolation and amplification of aerobic and facultative anaerobic mouse conjunctival commensal bacteria using a unique eye swab and culture-based enrichment step with subsequent identification by microbiological based methods and MALDI-TOF mass spectrometry.
04:44
Near-Infrared Spectroscopy During Reactive Hyperemia for the Assessment of Lower Limb Vascular Function
0 Views •
Cited by 3 •
2024
Here, we describe a non-invasive approach using near-infrared spectroscopy to assess reactive hyperemia in the lower limb. This protocol provides a standardized assessment of vascular and microvascular responsiveness that may be used to determine the presence of vascular dysfunction as well as the efficacy of therapeutic interventions.
FAQs
Inflammatory mediators released after exposure to pathogens, allergens, or irritants promote vasodilation in superficial conjunctival vessels. They also increase vascular permeability, allowing fluid movement that can contribute to swelling. These coordinated vascular responses explain why redness may occur together with other signs of ocular surface inflammation.
The location and intensity of redness provide information about the extent and pattern of conjunctival inflammation. Clinicians can use these features to evaluate ocular surface disturbance and support differential diagnosis, but interpretation should include associated findings such as swelling, discharge, discomfort, and the patient’s broader clinical context.
No. Pathogens, allergens, and irritation can all trigger inflammatory mediator release and produce ocular redness, so hyperemia by itself does not establish the underlying cause. Distinguishing among these possibilities requires considering its distribution and severity together with other observed findings, including discharge, swelling, and discomfort.
An examination should characterize how widely the redness is distributed and how severe it appears, then relate those observations to accompanying swelling, discharge, or discomfort. Recording these features creates a practical baseline for evaluating conjunctival inflammation and supports comparison with other clinical findings during assessment.
Because its distribution and severity can be observed, conjunctival hyperemia provides a readily available outcome for repeated evaluation. Changes in redness can help clinicians monitor disease progression and can also help assess responses to anti-inflammatory treatments when interpreted alongside the other signs of ocular surface disturbance.
It offers a visible indicator of host response at the ocular surface. Studies can examine hyperemia when investigating ocular infections, inflammatory reactions, and anti-inflammatory treatments, using its observed severity and distribution as outcomes that connect mediator-driven vascular responses with clinically apparent inflammation.